1. Home
  2. LQDT vs BBNX Comparison

LQDT vs BBNX Comparison

Compare LQDT & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDT
  • BBNX
  • Stock Information
  • Founded
  • LQDT 1999
  • BBNX 2015
  • Country
  • LQDT United States
  • BBNX United States
  • Employees
  • LQDT N/A
  • BBNX N/A
  • Industry
  • LQDT Catalog/Specialty Distribution
  • BBNX Medical/Dental Instruments
  • Sector
  • LQDT Consumer Discretionary
  • BBNX Health Care
  • Exchange
  • LQDT Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • LQDT 773.6M
  • BBNX 841.5M
  • IPO Year
  • LQDT 2006
  • BBNX 2025
  • Fundamental
  • Price
  • LQDT $23.57
  • BBNX $14.71
  • Analyst Decision
  • LQDT Strong Buy
  • BBNX Strong Buy
  • Analyst Count
  • LQDT 2
  • BBNX 10
  • Target Price
  • LQDT $38.50
  • BBNX $25.20
  • AVG Volume (30 Days)
  • LQDT 271.5K
  • BBNX 536.5K
  • Earning Date
  • LQDT 08-07-2025
  • BBNX 08-06-2025
  • Dividend Yield
  • LQDT N/A
  • BBNX N/A
  • EPS Growth
  • LQDT 23.09
  • BBNX N/A
  • EPS
  • LQDT 0.79
  • BBNX N/A
  • Revenue
  • LQDT $439,246,000.00
  • BBNX $69,830,000.00
  • Revenue This Year
  • LQDT $35.02
  • BBNX $32.79
  • Revenue Next Year
  • LQDT $9.90
  • BBNX $36.59
  • P/E Ratio
  • LQDT $29.72
  • BBNX N/A
  • Revenue Growth
  • LQDT 35.78
  • BBNX 38911.17
  • 52 Week Low
  • LQDT $19.31
  • BBNX $8.89
  • 52 Week High
  • LQDT $39.72
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • LQDT 46.09
  • BBNX N/A
  • Support Level
  • LQDT $22.89
  • BBNX N/A
  • Resistance Level
  • LQDT $23.87
  • BBNX N/A
  • Average True Range (ATR)
  • LQDT 0.67
  • BBNX 0.00
  • MACD
  • LQDT 0.19
  • BBNX 0.00
  • Stochastic Oscillator
  • LQDT 52.78
  • BBNX 0.00

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: